Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-28 Purchase |
2024-03-29 10:39 am |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
1,882 | $11.82 | $22,242 | 5,049 (Direct) |
View |
| 2022-10-06 Purchase |
2022-10-11 5:05 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
33,343 | $1.2878 | $42,940 | 63,343 (Direct) |
View |
| 2021-12-02 Purchase |
2021-12-02 5:09 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
10,000 | $1.39 | $13,900 | 30,000 (Direct) |
View |
| 2021-04-19 Purchase |
2021-04-20 7:56 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
10,000 | $1.82 | $18,200 | 20,000 (Direct) |
View |
| 2020-09-22 Purchase |
2020-09-22 5:14 pm |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
10,000 | $0.7245 | $7,245 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
208,700 | $0 | 208,700 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:11 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-05 5:07 pm |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
358,337 | $0 | 358,337 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:50 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:39 pm |
N/A 2032-10-05 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
71,998 | $0 | 71,998 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-24 5:39 pm |
N/A 2032-03-23 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
21,878 | $0 | 21,878 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-07 5:06 pm |
N/A 2031-10-05 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
47,335 | $0 | 47,335 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 6:08 pm |
N/A 2031-03-24 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
20,873 | $0 | 20,873 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-05 6:47 pm |
N/A 2030-10-05 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
160,474 | $0.5141 | 450,846 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 6:47 pm |
N/A 2030-10-01 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
290,372 | $0 | 450,846 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 6:06 pm |
N/A 2030-07-17 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
135,000 | $0 | 135,000 (Direct) |
View |